Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13400121 | 1.00 | CA2 (0.32) | CA2MAPT | |
| SCHEMBL3016063 | 1.00 | CA2 (0.32) | CA2MAPT | |
| SCHEMBL12532634 | 1.00 | CA2 (0.32) | CA2MAPT | |
| SCHEMBL13266323 | 1.00 | CA2 (0.32) | CA2MAPT | |
| SCHEMBL13832386 | 1.00 | CA2 (0.32) | CA2MAPT | |
| SCHEMBL20788826 | 1.00 | CA2 (0.32) | CA2MAPT | |
| SCHEMBL16730247 | 1.00 | CA2 (0.32) | CA2MAPT | |
| SCHEMBL15195755 | 1.00 | CA2 (0.32) | CA2MAPT | |
| SCHEMBL20788827 | 1.00 | CA2 (0.32) | CA2MAPT | |
| SCHEMBL14498943 | 1.00 | CA2 (0.32) | CA2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1872764-B1 | USE OF A SUGAR ALCOHOL IN COSMETIC COMPOSITIONS FOR SKIN AND WRINKLE IMPROVER | KAO CORP (JP) | 2018-09-26 | — | — | EP | disclosed |
| CN-101163462-B | Skin cosmetic and wrinkle-improving agent | KAO CORP | 2012-09-26 | — | — | CN | disclosed |
| US-20090069416-A1 | Cosmetic Composition for Skin and Wrinkle Improver | KAO CORPORATION (JP) | 2009-03-12 | — | — | US | disclosed |
| CN-101163462-A | Skin cosmetic and wrinkle-improving agent | KAO CORP (JP) | 2008-04-16 | — | — | CN | disclosed |
| EP-1872764-A1 | COSMETIC COMPOSITION FOR SKIN AND WRINKLE IMPROVER | Kao Corporation (JP) | 2008-01-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090069416-A1 | Cosmetic Composition for Skin and Wrinkle Improver | CUTA, GLA, COL1A1 | CA2 4700/4885MAPT 1815/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.